Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122145 · ClinicalTrials.gov registry record · Phase 1
Normal Breathing and Swallowing in Healthy Volunteers
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
NCT03122145 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 49 participants.
The verdict
NCT03122145, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to establish normative values for clinical testing measures of swallow, respiratory and cough functions. This will aide in establishing degree of impairment in disordered populations, and in identifying efficacious treatment paradigms for dysphagia.
Interventions
- DRUG Capsaicin
- DEVICE Videofluoroscopic swallow study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2019-02-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03122145
The ClinicalTrials.gov registry entry for NCT03122145 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Capsaicin is the first listed.
NCT03122145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03122145 about?
NCT03122145 is a clinical study titled "Normal Breathing and Swallowing in Healthy Volunteers". The purpose of this study is to establish normative values for clinical testing measures of swallow, respiratory and cough functions. This will aide in establishing degree of impairment in disordered populations, and in identifying efficacious treatment paradigms for dysphagia.
What is the current status of trial NCT03122145?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2017-05-23. Estimated completion is 2019-02-28.
What interventions are being tested in trial NCT03122145?
The interventions under investigation include: Capsaicin (DRUG), Videofluoroscopic swallow study (DEVICE).
Who is sponsoring clinical trial NCT03122145?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.